ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Accelerate Diagnostics, Inc. Investors to Inquire About Securities Class Action Investigation – AXDX – QNT Press Release


NEW YORK, Oct. 26, 2022 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) resulting from allegations that Accelerate Diagnostics may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Accelerate Diagnostics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=9377 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center